Skip to main content

Table 1 Distribution of Type-Specific Prevalent and Persistent Cervical High-Risk (hr) HPV Infections by HIV status

From: Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection

HPV Type Prevalent Infections Persistent Infections
Total
n = 517
HIV Negative
n = 247
HIV Positive
n = 270
Total
n = 473
HIV Negative
n = 223
HIV Positive
n = 250
hrHPV Positive 125 (24.2%) 37 (14.9%) 88 (32.6%) 51 (10.8%) 10 (0.0%) 41 (1.8%)
HPV 16 10 (1.9%) 2 (0.8%) 8 (2.9%) 4 (0.9%) 0 (0.0%) 4 (1.6%)
HPV 18 20 (3.9%) 5 (2.0%) 15 (5.5%) 5 (1.1%) 0 (0.0%) 5 (2.0%)
HPV 31 11 (2.1%) 1 (0.4%) 10 (3.7%) 6 (1.3%) 1 (0.5%) 5 (2.0%)
HPV 33 16 (3.1%) 3 (1.2%) 13 (4.8%) 4 (0.9%) 1 (0.5%) 3 (1.2%)
HPV 35 27 (5.2%) 5 (2.0%) 22 (8.1%) 14 (3.0%) 3 (1.4%) 11 (4.4%)
HPV 39 7 (1.3%) 2 (0.8%) 5 (1.8%) 2 (0.4%) 0 (0.0%) 2 (0.8%)
HPV 45 9 (1.7%) 4 (1.6%) 5 (1.8%) 1 (0.2%) 0 (0.0%) 1 (0.4%)
HPV 51 9 (1.7%) 1 (0.4%) 8 (2.9%) 3 (0.6%) 0 (0.0%) 3 (1.2%)
HPV 52 37 (7.1%) 12 (4.8%) 25 (9.2%) 18 (3.8%) 5 (2.2%) 13 (5.2%)
HPV 56 9 (1.7%) 4 (1.6%) 5 (1.8%) 1 (0.2%) 0 (0.0%) 1 (0.4%)
HPV 58 10 (1.9%) 2 (0.8%) 8 (2.9%) 3 (0.6%) 1 (0.5%) 2 (0.8%)
HPV 59 7 (1.3%) 0 (0.0%) 7 (2.5%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
  1. The table shows the number (percentage) of participants who were high-risk HPV positive at baseline